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ABSTRACT  
Yoni Vyapad is a compilation of various disorders of the genital tract ranging 
from vulva till the uterus. Local infectious conditions like vulvo vaginitis, pelvic 
inflammatory diseases have also been described. Among the various treatment 
modalities described for Yoni Vyapad, the emphasis given to Sthanika Chikitsa is 
noteworthy. The mode of approach through local route (with or without oral 
treatment) is with the aim to give instantaneous relief to the suffering woman. 
Pichu Prayoga is one such intervention among which “Shatavari ghrita pichu” 
has been specifically mentioned in the context of Pittaja Yoni Vyapad. The 
symptoms which are seen in the stubborn vulvo vaginitis conditions need 
effective treatment procedures. The use of a topical medicine like Pichu will act 
directly on the vaginal mucosa and enable easier and target specific action. 
Therefore it helps to combat the local disease causing agent and simultaneously 
strengthen the vagina as well as prevent recurrence. Simultaneous oral ingestion 
of the drug alongside, takes care of the complete eradication and relief of the 
disease symptoms. Since Ghrita is the best Pitta Shamaka, Shatavari Ghrita is 
chosen for our study in Pittaj Yonivyapad which is a Pitta pradhan vyadhi seen 
frequently these days. A Clinical Trial was carried out on 60 patients detected 
with Pittaj Yonivyapad with a trial group of 30 patients undergoing oral 
treatment of Shatavari Ghrita orally and Shatavari Ghrita Pichu vaginaly for 7 
days in comparison with same number of patients taking oral tablets of 
Clindamycin with Clindamycin pessaries kept vaginally for equal number of 
days. The drugs were prepared in the College Pharmacy and the Research 
conducted in the PTSR OPD of Loknete Rajaram Bapu Ayurvedic College, 
Hospital and PG Institute, of which we got satisfactory results of 50 – 75% in 
comparison with the allopathic drugs for Pelvic Inflammatory Disease. 
INTRODUCTION
 A healthy woman is a promise of a healthy 
family and a woman’s health status is a complex 
arrangement controlled by a wide range of factors 
headed by her reproductive system. The significance of a 
healthy Yoni has been asserted in various phases of a 
woman’s life from puberty to marriage to child birth and 
thereafter.[1] The word Yoni has been mentioned with 
reference to female reproductive system at various levels 
especially with reference to the vagina, uterus and 
sometimes the reproductive tract as a whole.[2] 
 Pittaj  Yonivyapad  is one  of the  frequently  seen  
gynecological  disorder remains    one  among  those 
which cause considerable morbidity affecting both 
physical as well as psychology of the women. It is 
observed that physiological state of body changes 
throughout the life span. As per Ayurveda, Tridoshas 
should be at Prakrut avastha. With the technological 
development social life has undergone huge changes. 
With change in lifestyle people adapted new habits like 
Mithya aahara vihara like eating spicy food, fast food, 
travelling in hot polluted atmosphere, for spacing the 
family usage of various types of contraceptives like OC 
pills and Cu-T insertion etc,. which are harmful to 
women's health. A detailed description of the disease of 
female genital tract is described in Ayurveda[3] under the 
chapter on Yonivyapads. Charak has described 20 
different types of disease of the genital tract and Pittaj 
Yonivyapad is one of the common and important 
Yonivyapads. 
  In Rajaswala stage i.e. (Reproductive age 20-40 
years) Pitta dosha pradhanyata is seen and if woman 
indulges in Pittakara aahar vihar in this stage it causes 
Pitta dushti and can cause Pitta pradhan vyadhis. Pittaj 
Yonivyapad is one among this due to excessive intake of 
Katu, Amla, Lavana, Kshara aahara, Pitta gets vitiated 
and reaches Tryavarta yoni and leads to Daha, Paka, 
Ushna, Raja adhikya, Neel peeta rajasrava, and many 
times Jwara is seen as Sarvadehik lakshan. 
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 Based on the characteristics of Pittaj Yonivyapad 
it has been observed that features mimic Pelvic 
inflammatory disease. Throughout the world there is 
increasing rate of pelvic infection due to rise in STDs. 
 According to CDC (Centers for Disease Control) 
incidence of Pelvic Inflammatory Disease 24-32% 
women in India in 2013-14.From 1995-2001, 769,859 
cases of Pelvic Inflammatory Disease were reported in 
The United States annually. The Center For Disease 
Control And Prevention has estimated that more than 1 
million women experience an episode of Pelvic 
Inflammatory Disease every year. The disease leads to 
approximately 2.5 million OPD visits and 125,000-
150,000 hospitalization yearly. Some are identified and 
treated whereas most are overlooked.[4] 
Increased incidence of STDs and correspondingly PID is 
due to. 
- Increased permissive sexual attitude together with 
the ready availability of contraception. 
- The incidence varies from 1% -2% per year among 
sexually active women. About 85% are spontaneous 
infection in sexually active females of reproductive 
age. 
- The remaining 15% follow procedures which favors 
the organisms to ascend up. Such iatrogenic 
procedures include –Endometrial biopsy, 
- Uterine curettage 
- Insertion of Intra uterine device & Hystero-
salpingogram.  
 Keeping in view all these factors, a woman who 
is afflicted with Pittaj Yonivyapad[5,6,7,8], if not properly 
intervened in right time, in long run she may come out 
with various complications in the form of infertility etc. 
 In modern system of medicine antimicrobials, 
analgesic, NSAID’s are often prescribed in the treatment 
of Pelvic Inflammatory Disease. Gastrointestinal upset 
which are increased by analgesics and anti-inflammatory 
drugs, which also produce headache, dizziness, 
drowsiness. The aim of this study is to find out a safe, 
potent, nonsurgical management for Pelvic Inflammatory 
Disease.  
 Management of Pittaj Yonivyapad in classics has 
been described as being treated by using Raktapittahara 
Chikitsa Sheetaveerya Dravyas, therapies like Seka, 
Abhyanga and Pichudharana etc.  
AIMS 
 To evaluate clinical efficacy of Brihat Shatavari 
Ghrita orally and locally (In the form of Pichu) in Pittaj 
Yonivyapad  
OBJECTIVES 
To study the Pittaj Yonivyapad in detail.  
- Conceptual study of Pelvic Inflammatory Disease in 
detail 
- To study the properties and actions of Shatavari 
Ghrita in detail. 
- Comparative study of Pittaj Yonivyapad & PID. 
NIDANA FOR PITTAJ YONIVYAPAD 
Vishesha nidanas for Pittaj Yonivyapad are as follows : 
 These are mainly Pitta prakopaka factors. Katu, 
Amla, Lavana, Kshara padartha atisevana. Along with this 
other factors are: Teekshna, Vidahi and Ushna padartha 
Atisevana, other articles of food include : 
- Kulatha  
-  Sarshapa 
- Takra 
- Amla phala 
- Sura vikara 
- Shukta sevana 
- Dhanyamla sevana 
- Tila anna sevana etc.  
- Vihara include: upavasa,  bhaya,  ayasa,  irsha and 
shoka. 
SAMPRAPTI OF PITTAJ YONIVYAPAD 
Pittaprakopaka ahara and vihara 
 
Vitiates pitta dosha 
 
Enters yoni 
 
Produces Pittaj Yonivyapad 
SAMPRAPTI GHATAKAS 
Dosha - Pitta,  Vata. 
Dushya - Rasa,  Rakta 
Srotas – Artavavaha 
Udabhava sthana - Amashaya 
Roga marga - abhyantara 
Adhisthana – Yoni,  Garbhashaya 
Srotodushti prakara - Sanga 
Vyakta sthana - Yoni,  Garbhashaya 
LAKSHANAS: 
According to Charaka 
- Daha 
- Paka 
- Jwara 
- Ushna kamita 
- Artava is Neela,  Peeta and Asita. 
- Srava - which is Bhrusha, Ushna and Kunapa. 
According to Sushruta 
- Daha 
- Paka 
- Jwara 
- Acharya Dalhana mentions there may be 
manifestations of Lakshanas like Osha,[7] Chosha,  
Paridaha,  Dhoomayana etc. 
According to Vagbhata 
- Daha 
- Paka 
- Jwara 
VYAVACHEDAKA NIDANA: 
The conditions from which Pittaj Yonivyapad can be 
differentiated are: 
1. Pittaja artava dushti 
2. Raktaja artava dushti 
3. Pittaja rakta pradara 
PITTAJ YONIVYAPAD CHIKITSA 
1. In all Yonivyapad[8] caused due to Pitta dosha, Sheetala 
Chikitsa should be done or Raktapittahara measures 
should be adopted.  
Mulla Iram Bano et al. Brihat Shatavari Ghrita Locally and Orally in Pittaj Yonivyapad  
AYUSHDHARA | March - April 2016 | Vol 3 | Issue 2  654 
2. Therapies like Seka, Abhyanga and Pichu kriya must be 
performed with the drugs having Sheetala properties. 
3. Uttarabasti should be given with Ksheera prepared 
from Madhura drugs or Madhuka. (Charak samhita 
chiktsa 30/85)  
4. Kalkadharana  
Panchavalkala kalkadharana should be done in Pittaj 
Yonivyapad. (Charak Samhita Chikitsa 30/62)  
Preparation of ghrita kalpana 
 Sneha kalpana [9,10,11,12] is prepared by taking 
Sneha in one Matra, drug Kalka in 1/4th of Sneha and 
adding Drava (liquid) four times of Sneha. Heating the 
given combination till following characters are observed 
gives the Sneha kalpana. 
1. The drug Kalka could be melted in Varti with two 
fingers. 
2. If the Kalka is exposed to fire no sound is observed. 
3. "Phen shanti"[13], that means no further bubbles are 
observed over Ghrita while heating it. 
4. Ghrita gets all the characters of crude drug by which 
it was medicated, such as smell, taste, color and its 
medicinal properties. 
 Thus when this Sneha gets prepared finally, it 
could be used for massaging the body, taking it orally, for 
the purpose of Nasya, Gandush, Basti, oiling the eyes, 
Vrana chikita, Pichu dharan etc. 
Indication for Ghrita sevan 
 Intake of Ghrita is prescribed for those whose 
bodily constitution is dominated by Vata and Pitta, who 
is suffering from disease due to vitiation of Vata and 
Pitta, those desirous of strength, good complexion, voice, 
nourishment, progeny, tenderness, luster, Ojas, memory, 
intelligence, power of digestion, wisdom, proper 
functioning of sense organs and those afflicted with 
injuries due to burns, by weapons, poison and fire. 
Absorption of drug through vagina- Vagina is 
preferred as a route for drug delivery because of its 
anatomical position which favors secure retention of 
vaginal formulation. The vaginal defense (i.e. epithelium, 
flora, immune cells and pH), microbiology and 
vascularity make it ideal for absorbing drugs. Now, 
potential for systemic delivery through vagina was 
explored due to its large surface area, high vascularity 
and permeability to a wide range of compounds 
including peptides and proteins. 
MATERIALS AND METHODS 
Source of data 
1. 60 patients diagnosed as Pittaj Yonivyapad (PID) 
attending O.P.D. of our institution and fulfilling 
criteria was taken for the study.  
2. A special Performa was prepared with all points of 
history taking, physical sign and symptoms and lab 
investigations. The parameters were scored on the 
basis of standard methods of statistical Analysis.  
3. Selected patients were divided into two groups of 30 
patients each.  
Inclusive Criteria 
- Married females  
- Patients within the age group of 20-40 years.  
- Diagnosed cases of Pittaj Yonivyapad (PID) 
- Written informed consent and voluntary willing 
patients were taken for this study. 
Exclusive Criteria  
- Pregnant females  
- H/o DM, HTN, Asthma.  
- Patients who require surgical interventions in cases 
like pelvic Abscess, Tubo ovarian mass etc. 
- Patients with PID when seen associated with 
prolapsed uterus.  
- PID associated with tubercular infections. 
- Patients with exclusively vulvitis and bartholinitis.  
- PID when complicated with Diabetes.  
- HIV, HBsAg, VDRL Positive  
- Patients with benign and malignant tumors of the 
uterus.  
- STD, IUCD disease.  
Investigations 
- CBC 
- HIV, VDRL, HBsAg 
- Urine Routine and Microscopic  
- Pap smear 
- USG (if required) 
PARAMETERS FOR ASSESSMENT 
Subjective Parameter  
1) Daha  
Absent : 0 
Mild  : 1 
Moderate (Subsides on its own) : 2 
Severe (Needs medicines to subside) : 3 
2) Srava – praman 
No discharge  : 0 
Occasional discharge   : 1 
Discharge sufficient to wet the 
undergarment 
 
: 
 
2 
Heavy discharge   : 3 
3) Mutradaha  
Absent : 0 
Occasional : 1 
Moderate relief by cold water wash : 2 
Severe : 3 
4) Backache 
No pain : 0 
Pain during menses, intercourse,  
No interference with routine work 
: 1 
continuous pain interferes with routine 
subsides after medication 
 
: 
2 
Continuous pain interferes with routine 
work no relief with medication 
: 3 
5) Ruja (Adhodar Shoola)  
No pain : 0 
Mild : 1 
Moderate : 2 
Severe : 3 
Objective parameters  
1) Paka of Vulva 
Normal (Pink color)  : 0 
Mild (Slight deviation towards red) : 1 
Moderate (red)  : 2 
Severe (Bright red) : 3 
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2) Tenderness 
No Adnexal tenderness : 0 
Adnexal tenderness  : 1 
Cervical motion tenderness  : 2 
Mass felt through fornices   : 3 
3) Fever 
Absent : 0 
Mild (97.60-990f) : 1 
Moderate (990-1000f) : 2 
Severe(1000-1010f) : 3 
Level of Percentage of Relief  
Difference between pre and post treatment symptom 
score 
Cured : All symptoms Disappeared-100% 
Remarkable 
improvement 
 
: 
 
Relief in between 50-75% 
Improved : Relief in between 25-50% 
Unchanged : Relief < 25% 
STUDY DESIGN 
Group A (Trial Group)  
 30 diagnosed patients of Pittaj Yonivyapad were 
administered Shatavari Ghrita orally for 7 days and 
Shatavari Ghrita Pichu Dharan (Vaginally) for 7 days.  
 Shatavari Ghrita (orally) 
Dose: - 12gm once a day (approximately 3 tsf.)  
Anupana:-Go dugdha 
Kala:-Pratah kala on empty stomach (between 6 to 8 
am.) 
Duration:-7 days. 
Follow up:-daily for 7 days. 
Next follow up:-on 14th day  
 Method of Pichu Dharan 
Brihat Shatavari Ghrita Pichu Dharan (vaginally) 
Procedure 
- Patient was advised to come after her menstruation.  
- After evacuation of the bladder patient was made to 
lie in lithotomy position  
- Vulva and surrounding area was cleaned with 
antiseptic lotion.  
- Pichu was prepared with Shatavari Ghrita and 
inserted deep into the vagina touching the cervix 
- Patient was asked to retain it for 4 hours.  
- Same Procedure was continued for 7 days.  
Kala :- Day time (for 4 hours) once in a day 
Duration :- 7 days  
Follow up:- daily for 7 days. 
Next follow up:- on 14th day  
Group B (control group) 
 30 diagnosed patients of Pittaj Yonivyapad (PID) 
were administered.  
Tab. Clindamycin 450 mg qid ( 4 times in a day ) for 7 
days. Followed by Clindamycin 100 mg vaginal pessary 
HS for 7 days. 
Follow up :- daily for 7 days. 
Next follow up :-on 14th day  
METHOD OF PREPARATION OF DRUG: 
- Raw drugs required were authentically identified and 
preparation was done in College Pharmacy.  
- Ghrita was prepared according to Sharangdhara 
samhita.[14]  
Method of Preparation of Brihat Shatavari Ghrita 
  Brihat Shatavari Ghrita was prepared according 
to Sarangdhara Samhita. Jeevak, Rishbhak, Meda, 
Mahameda, Kakoli, Kshirkakoli drugs are not available 
therefore their Pratinidhi drugs i.e. Vidari, Ashwagandha 
& Shatavari were taken in double quantity. Rests of the 
ingredients of the compound were taken in one-one part. 
The quantity of Ghrita was taken twice the whole drugs. 
The quantity of milk was taken four times to Ghrita. 
OBSERVATIONS 
Table 1: According to Change in Daha 
Daha Day-0 Day-14  
% Relief 
Wilcoxon Signed 
Ranks Test Z 
 
P Mean score Sd Mean score Sd 
Group-A 1.97 1.066 .67 .711 66.1 4.594 <0.001 HS 
Group-B 1.83 .874 .40 .675 78.2 4.651 <0.001 HS 
In trial group-A: The mean score for B.T. was 1.97 & had changed to. 711 after treatment, by Wilcoxon Signed Rank 
test it was found that change from B.T. to A.T. was highly significant as P value <0.001. 
In Control group-B: The mean score for B.T. was 1.83 & had changed to. 40 after treatment, by Wilcoxon Signed Rank 
test it was found that change from B.T. to A.T. was highly significant as P value <0.001. 
Table 2: According to Change in Srava 
Srava  
praman 
Day-0 Day-14 % 
Relief 
Wilcoxon Signed 
Ranks Test Z 
 
P Mean score Sd Mean score Sd 
Group-A 2.03 .809 .77 .626 62.3 4.597 <0.001 HS 
Group-B 1.83 .747 .40 .621 78.2 4.667 <0.001 HS 
In trial group-A the mean score for B.T. was 2.03 & had changed to. 77 after treatment, by Wilcoxon Signed Rank test it 
was found that change from B.T. to A.T. was highly significant as P value <0.001. 
In Control group-B the mean score for B.T. was 1.83 & had changed to. 40 after treatment, by Wilcoxon Signed Rank 
test it was found that change from B.T. to A.T. was highly significant as P value <0.001. 
Table 3:  According to Change in Mutradaha 
Mutradaha 
Day-0 Day-14 % 
Relief 
Wilcoxon Signed 
Ranks Test Z 
 
P Mean score Sd Mean score Sd 
Group-A 2.00 .947 2.00 .699 58.3 4.419 <0.001 HS 
Group-B 1.63 .890 1.63 .606 79.6 4.481 <0.001 HS 
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In trial group-A the mean score for B.T. was 2.00 & had changed to. 69 after treatment, by Wilcoxon Signed Rank test it 
was found that change from B.T. to A.T. was highly significant as P value <0.001. 
In Control group-B the mean score for B.T. was 1.63 & had changed to. 60 after treatment, by Wilcoxon Signed Rank 
test it was found that change from B.T. to A.T. was highly significant as P value <0.001. 
Table 4: According to Change in Backache 
Backache 
Day-0 Day-14 % 
Relief 
Wilcoxon Signed 
Ranks Test Z 
 
P Mean score Sd Mean score Sd 
Group-A 2.03 .765 .80 .761 60.7 4.604 <0.001 HS 
Group-B 1.40 .675 .73 .583 47.6 4.472 <0.001 HS 
In trial group-A the mean score for B.T. was 2.03 & had changed to. 80 after treatment, by Wilcoxon Signed Rank test it 
was found that change from B.T. to A.T. was highly significant as P value <0.001. 
In Control group-B the mean score for B.T. was 1.40 & had changed to. 73 after treatment, by Wilcoxon Signed Rank 
test it was found that change from B.T. to A.T. was highly significant as P value <0.001. 
Table 5: According to Change in Ruja 
Ruja 
Day-0 Day-14 % 
Relief 
Wilcoxon Signed Ranks 
Test Z 
 
P Mean score Sd Mean score Sd 
Group-A 2.23 .817 .73 .521 67.2 4.755 <0.001 HS 
Group-B 1.80 .847 .40 .498 77.8 4.584 <0.001 HS 
In trial group-A the mean score for B.T. was 2.23 & had changed to. 73 after treatment, by Wilcoxon Signed Rank test it 
was found that change from B.T. to A.T. was highly significant as P value <0.001. 
In Control group-B the mean score for B.T. was 1.80 & had changed to. 40 after treatment, by Wilcoxon Signed Rank 
test it was found that change from B.T. to A.T. was highly significant as P value <0.001. 
Table 6: According to Change in Paka of Vulva 
Paka of vulva 
Day-0 Day-14 % 
Relief 
Wilcoxon Signed 
Ranks Test Z 
 
P Mean score Sd Mean score Sd 
Group-A 2.00 .587 .60 .621 70.0 4.752 <0.001 HS 
Group-B 1.53 .819 .33 .547 78.3 4.512 <0.001 HS 
In trial group-A the mean score for B.T. was 2.00 & had changed to. 60 after treatment, by Wilcoxon Signed Rank test it 
was found that change from B.T. to A.T. was highly significant as P value <0.001. 
In Control group-B the mean score for B.T. was 1.53 & had changed to. 33 after treatment, by Wilcoxon Signed Rank 
test it was found that change from B.T. to A.T. was highly significant as P value <0.001 
Table 7: According to Change in Tenderness 
Tenderness 
Day-0 Day-14 % 
Relief 
Wilcoxon Signed 
Ranks Test Z 
 
P Mean score Sd Mean score Sd 
Group-A 1.93 .583 .77 .626 60.3 4.882 <0.001 HS 
Group-B 1.60 .814 .57 .774 64.6 4.625 <0.001 HS 
In trial group-A the mean score for B.T. was 1.93 & had changed to. 77 after treatment, by Wilcoxon Signed Rank test it 
was found that change from B.T. to A.T. was highly significant as P value <0.001. 
In Control group-B the mean score for B.T. was 1.60 & had changed to. 57 after treatment, by Wilcoxon Signed Rank 
test it was found that change from B.T. to A.T. was highly significant as P value <0.001. 
Table 8: According to Change in Fever 
Fever 
Day-0 Day-14 % 
Relief 
Wilcoxon Signed 
Ranks Test Z 
 
P Mean score Sd Mean score Sd 
Group-A .80 .551 .13 .346 83.3 4.264 <0.001 HS 
Group-B .50 .509 .03 .183 93.3 3.742 <0.001 HS 
In trial group-A the mean score for B.T. was. 80 & had changed to. 13 after treatment, by Wilcoxon Signed Rank test it 
was found that change from B.T. to A.T. was highly significant as P value <0.001. 
In Control group-B the mean score for B.T. was. 50 & had changed to. 03 after treatment, by Wilcoxon Signed Rank test 
it was found that change from B.T. to A.T. was highly significant as P value <0.001. 
Table 9: Percentage Relief 
Symptoms Group-A (Trial Group) Group-B (Control Group) 
Daha 66.1 78.2 
Srava-Praman 62.3 78.2 
Mutradaha 58.3 79.6 
Backache 60.7 47.6 
Ruja 67.2 77.8 
Paka Of Vulva 70.0 78.3 
Tenderness 60.3 64.6 
Fever 83.3 93.3 
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Table 10: Percentage Relief 
Overall Effect No. of symptoms 
Group-A Group-B 
No change (<25%) 0 0 
Mild change (25% – 49.9%) - 1 
Moderate change (50% -74.9%) 8 3 
Good change (75% +) 2 6 
 Above distribution shows that there is<25 to no 
change, improved in zero symptom, where as there is 25 
to 49.9% cured in 1 symptom i.e. backache, 50 to 74.9% 
cured in 8 symptoms i.e. Daha, Sravapraman, Mutradaha, 
Ruja, Paka of vulva and tenderness. 75% cured in 2 
symptoms i.e. Srava and Fever. 
DISCUSSSION 
 The etiologies given for Pittaj Yonivyapad are 
mainly the dietetic factors like Kshara,  Amla,  Lavana, 
katu etc which are mainly the Pitta vitiating factors. 
CONCLUSION 
The conclusions that have been drawn from the study are 
 Features of Pittaj Yonivyapad have close 
resemblance with Pelvic Inflammatory Disease. 
  The treatment which includes Brihat Shatavari 
Ghrita locally (Pichu Dharan vaginally) and orally has 
been used based on their properties like Sheeta 
veerya, Madhura rasa, Daha prashamana, Srava hara 
and Vedana shamaka - all these objectives are 
fulfilled to a greater extent.  
 Among the available treatment for Pittaj Yonivyapad, 
Brihat Shatavari Ghrita pichu and taken orally is 
beneficial in curing the vitiated Pitta dosha. 
 Total effect of the combined therapy on Daha 
contributes about 66.1% after treatment and 70.0% 
for Paka. 
 So it can be concluded that Brihat Shatavari Ghrita is 
preparable, effective, potent, easily administrable 
type of treatment. 
 It is also noted that, Brihat Shatavari Ghrita orally 
and locally (Pichu Dharan) i.e.-A (trial drug) has 
shown mild better results in some symptom of Pittaj 
Yonivyapad i.e. Srava and Backache. 
 Since the clinical study was conducted on a limited 
number of patients it may not be claimed as final. 
More detailed study may be needed in this regard to 
establish the efficacy of Brihat Shatavari Ghrita 
orally and locally (Pichu). 
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